BridgeMD
Prevention study for HIV Infected Individuals
Official title Zoledronic Acid for the Prevention of TDF-sparing ART-induced Bone Mass Density Loss in Treatment-naive HIV Positive Individuals
ClinicalTrials.gov ID: NCT06762730
What this study is testing
What is Zoledronic Acid 5 mg/Bag 100 ml Inj?
Zoledronic Acid 5 mg/Bag 100 ml Inj is an investigational medicine, being studied as a potential treatment for hiv infected individuals.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial is to learn if zolendric acid can prevent the anticipated deterioration of bone mass after antiviral treatment initiation for people that were recently diagnosed with HIV. The main questions it aims to answer are: 1.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults over age of 18 years old of any gender, social, religious or racial background.
- Confirmed positive result for HIV infection.
You likely can't join if
- Patients who received previous pharmacological agents for the prevention of HIV infection.
- Women who are pregnant, lactating or those who plan to become pregnant within the trial timeframe.
- Past history of severe drug-induced reaction (including atypical femur fractures or osteonecrosis of the jaw) or documented hypersensitivity to a...
- Patients with untreated hypocalcemia at screening.
- Severe dental status
The study team makes the final eligibility decision.
Where it's taking place
- Haifa, Israel
- Jerusalem, Israel
- Ramat Gan, Israel
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Haifa, Israel; Jerusalem, Israel; Ramat Gan, Israel. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.